InfuSystem - Public Comps and Valuation Multiples

InfuSystem Overview

About InfuSystem

InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. INFU services are provided under a two-reportable segment. The first is Patient Services, providing the last-mile solution for clinic-to-home healthcare where the continuing treatment involves complex durable medical equipment and services. The Patient segment is comprised of Oncology, Pain Management and Wound Therapy businesses. The second, Device Solutions, supports the Patient Services platform and leverages service orientation to win incremental business from its direct payer clients. The Device segment is comprised of direct payer rentals, pump and consumable sales, and biomedical services and repair. Majority from Patient.

Founded

2005

HQ

Employees

514

Website

infusystem.com

Sectors

Medical Devices
DeepTech
HealthTech

Financials

LTM Revenue $138M

LTM EBITDA $26.1M

EV

$133M

Valuation Multiples

Multiples.vc

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

InfuSystem Financials

InfuSystem has a last 12-month revenue of $138M and a last 12-month EBITDA of $26.1M.

In the most recent fiscal year, InfuSystem achieved revenue of $135M and an EBITDA of $19.3M.

InfuSystem expects next 12-month revenue of XXX and NTM EBITDA of XXX

See InfuSystem valuation multiples based on analyst estimates

InfuSystem P&L

	FY 2023	FY 2024	FY 2025	LTM	NTM
Revenue	$126M	$135M	XXX	XXX	XXX
Gross Profit	$62.6M	$63.1M	XXX	XXX	XXX
Gross Margin	50%	47%	XXX	XXX	XXX
EBITDA	$16.5M	$19.3M	XXX	XXX	XXX
EBITDA Margin	13%	14%	XXX	XXX	XXX
Net Profit	$18K	$0.9M	XXX	XXX	XXX
Net Margin	0%	1%	XXX	XXX	XXX
Net Debt	$33.0M	$28.9M	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

InfuSystem Stock Performance

As of April 15, 2025, InfuSystem's stock price is $5.

InfuSystem has current market cap of $105M, and EV of $133M.

See InfuSystem trading valuation data

InfuSystem Stock Data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$133M	$105M	XXX	XXX	XXX	XXX	$0.14

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

InfuSystem Valuation Multiples

As of April 15, 2025, InfuSystem has market cap of $105M and EV of $133M.

InfuSystem's trades at 1.0x LTM EV/Revenue multiple, and 5.1x LTM EBITDA.

Analysts estimate InfuSystem's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

See valuation multiples for InfuSystem and 10K+ public comps

InfuSystem Financial Valuation Multiples

	FY 2024	FY 2025E	FY 2026E	FY 2027E
EV	$133M	XXX	XXX	XXX
EV/Revenue	1.0x	XXX	XXX	XXX
EV/EBITDA	6.9x	XXX	XXX	XXX
P/E	44.8x	XXX	XXX	XXX
P/E/Growth	0.6x	XXX	XXX	XXX
EV/FCF	50.6x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get InfuSystem Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

InfuSystem Valuation Multiples

InfuSystem's NTM/LTM revenue growth is 9%

InfuSystem's revenue per employee for the last fiscal year averaged $0.3M, while opex per employee averaged $0.1M for the same period.

Over next 12 months, InfuSystem's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .

Analysts estimate InfuSystem's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

See operational valuation multiples for InfuSystem and other 10K+ public comps

InfuSystem Operational Valuation Multiples

	FY 2024	NTM	FY 2025E	FY 2026E	FY 2027E
Revenue Growth	7%	XXX	XXX	XXX	XXX
EBITDA Margin	14%	XXX	XXX	XXX	XXX
EBITDA Growth	17%	XXX	XXX	XXX	XXX
Rule of 40 (SaaS-only)	23%	XXX	XXX	XXX	XXX
Revenue per Employee	$0.3M	XXX	XXX	XXX	XXX
Opex per Employee	$0.1M	XXX	XXX	XXX	XXX
S&M Expenses to Revenue	8%	XXX	XXX	XXX	XXX
G&A Expenses to Revenue	38%	XXX	XXX	XXX	XXX
R&D Expenses to Revenue	n/a	XXX	XXX	XXX	XXX
Opex to Revenue	47%	XXX	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry